Wolcott-Rallison Syndrome Due to a Novel Mutation (R491X) in EIF2AK3 Gene
PDF

Case Report

Wolcott-Rallison Syndrome Due to a Novel Mutation (R491X) in EIF2AK3 Gene

J Clin Res Pediatr Endocrinol 2012;4(2):101-103 DOI: 10.4274/Jcrpe.619
, , , ,
PDF
Permissions

Abstract

Wolcott-Rallison syndrome (WRS) is a rare autosomal recessive disordercharacterized by early-onset diabetes, spondyloepiphyseal dysplasia,tendency to skeletal fractures secondary to osteopenia, and growthretardation. Mutations in the eukaryotic translation initiation factor 2αkinase (EIF2AK3)gene are responsible for this disorder. Here, wedescribe a boy with neonatal diabetes, diagnosed at 2 months of age,who developed severe growth retardation and a skeletal fracture duringthe follow-up period. The patient’s skeletal X-ray revealed findings ofskeletal dysplasia. A clinical diagnosis of WRS was confirmed by theidentification of a novel homozygous nonsense mutation (R491X) in exon9 of the EIF2AK3 gene. The aim of this report is to raise the awarenessfor Wolcott-Rallison syndrome in cases presenting with isolatedneonatal diabetes. This patient demonstrates that the other findings ofthis syndrome might be obscured by a diagnosis of isolated neonataldiabetes.

Keywords: Wolcott-Rallison syndrome, neonatal diabetes, Skeletal dysplasia

Read the full text

1 section · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.